These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15745782)

  • 41. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
    Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
    Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using (125)I, (103)Pd, and (131)Cs and historical perspective.
    Leonard KL; Gagne NL; Mignano JE; Duker JS; Bannon EA; Rivard MJ
    Brachytherapy; 2011; 10(4):331-9. PubMed ID: 21349775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
    Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
    Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Criteria for assessing the efficacy of brachytherapy of uveal melanomas, complications of therapy and there prevention].
    Brovkina AF; Zarubeí GD; Val'skií VV
    Vestn Oftalmol; 1997; 113(3):14-6. PubMed ID: 9265351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial.
    Horgan N; Shields CL; Mashayekhi A; Salazar PF; Materin MA; O'Regan M; Shields JA
    Ophthalmology; 2009 Jul; 116(7):1383-90. PubMed ID: 19481812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitreous hemorrhage after plaque radiotherapy for uveal melanoma.
    Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
    Retina; 2012 Jun; 32(6):1156-64. PubMed ID: 22366905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy.
    Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
    Ophthalmic Surg Lasers; 1995; 26(5):449-60. PubMed ID: 8963860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathologic findings in recurrent choroidal melanoma after transpupillary thermotherapy.
    Diaz CE; Capone A; Grossniklaus HE
    Ophthalmology; 1998 Aug; 105(8):1419-24. PubMed ID: 9709752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma.
    Jensen AW; Petersen IA; Kline RW; Stafford SL; Schomberg PJ; Robertson DM
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):101-8. PubMed ID: 16111577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma.
    Nagendran ST; Finger PT
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):201-7. PubMed ID: 25707045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of melanoma cell type in uveal melanoma following treatment failure.
    Char DH; Miller T; Crawford JB
    Am J Ophthalmol; 2004 Oct; 138(4):543-6. PubMed ID: 15488778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
    Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Collaborative ocular melanoma study randomized trial of I-125 brachytherapy.
    Hawkins BS
    Clin Trials; 2011 Oct; 8(5):661-73. PubMed ID: 22013172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sector laser photocoagulation for the prevention of macular edema after plaque radiotherapy for uveal melanoma: a pilot study.
    Materin MA; Bianciotto CG; Wu C; Shields CL
    Retina; 2012 Sep; 32(8):1601-7. PubMed ID: 22466484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
    Frenkel S; Hendler K; Pe'er J
    Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma.
    Mantel I; Schalenbourg A; Bergin C; Petrovic A; Weber DC; Zografos L
    Am J Ophthalmol; 2014 Oct; 158(4):693-701.e2. PubMed ID: 25034116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.
    van Ginderdeuren R; van Limbergen E; Spileers W
    Br J Ophthalmol; 2005 Oct; 89(10):1306-10. PubMed ID: 16170122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Scleral patch grafts in the management of uveal and ocular surface tumors.
    Barman M; Finger PT; Milman T
    Ophthalmology; 2012 Dec; 119(12):2631-6. PubMed ID: 22858126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Brachytherapy in choroidal melanoma].
    Starzycka M; Słomska J; Romanowska B
    Klin Oczna; 1999; 101(1):19-22. PubMed ID: 10401209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation.
    Char DH; Castro JR; Quivey JM; Phillips TL; Irvine AR; Stone RD; Kroll S
    Ophthalmology; 1989 Dec; 96(12):1708-15. PubMed ID: 2695875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.